School of Medicine

Researchers at the School of Medicine have identified a marker of damage to cells in the eye that potentially could be used to monitor progression of glaucoma and the effectiveness of treatment.

Travis Conrad Mazer, a doctoral candidate studying molecular genetics and genomics, died unexpectedly Monday, April 24, 2017, in St. Louis. Mazer was 25. A Kalamazoo, Mich., native who was fascinated by science and politics, Mazer began working toward a PhD in August at Washington University School of Medicine in St. Louis.

Using new gene-editing technology, researchers at the School of Medicine have rewired mouse stem cells to fight inflammation caused by arthritis and other chronic conditions.

Methodius Tuuli, MD, an associate professor of obstetrics and gynecology at Washington University School of Medicine in St. Louis, and colleagues have been recognized with a 2017 Top 10 Clinical Research Achievement Award from the Clinical Research Forum.

Leila Sadat, an internationally renowned human rights expert, and David C. Van Essen, an authority on brain structure, function and development, will receive the university’s 2017 faculty achievement awards, Chancellor Mark S. Wrighton announced. Eric Leuthardt, MD, will be honored for innovation and entrepreneurship.

Jeffrey R. Millman, an assistant professor of medicine in the Division of Endocrinology Metabolism & Lipid Research at Washington University School of Medicine in St. Louis, has received a 2017 Career Development Award from the Juvenile Diabetes Research Foundation.

A team led by Washington University School of Medicine scientists has found a way to measure tau levels in the blood. Damaging tangles of the protein tau dot the brains of people with Alzheimer’s and other neurodegenerative diseases.

To help people with hearing loss navigate their daily lives, Nancy Tye-Murray and colleagues at the School of Medicine have developed software tools to improve speech recognition. She launched a startup to provide the software to patients and professionals.

David H. Gutmann, MD, PhD, an international leader in neurofibromatosis research, received a $3.5 million grant to study why people with a genetic mutation that causes the genetic disorder known as NF1 develop markedly different signs and symptoms.

Washington University health researcher Ross Brownson has received a five-year, $2.6 million grant from the National Cancer Institute of the National Institutes of Health (NIH) for a study examining poor implementation of cancer-control programs.